December 28, 2014 3:58 PM ET

Pharmaceuticals

Company Overview of Fovea Pharmaceuticals SA

Company Overview

Fovea Pharmaceuticals SA, a biopharmaceutical company, engages in the discovery and development of drugs for the treatment of ocular diseases. It provides FOV1101/Prednisporin for the treatment of allergic conjunctivitis; FOV2302, a proprietary plasma kallikrein-kinin inhibitor for systemic treatment of hereditary angioedema; FOV2304 for the treatment of diabetic macular edema; and FOV2501, an intravitreal formulation of RdCVF designed to treat retinitis pigmentosa with extension to dry age related macular degeneration. The company was founded in 2005 and is based in Paris, France. As of October 30, 2009, Fovea Pharmaceuticals SA operates as a subsidiary of Sanofi.

Institut de la Vision

17 rue Moreau

Paris,  75012

France

Founded in 2005

Phone:

33 1 44 16 42 42

Fax:

33 1 44 16 42 40

Key Executives for Fovea Pharmaceuticals SA

Co-Founder and Chairman of Scientific Advisory Board
Chief Financial Officer and Strategic Controller
Administration and Finance Director
Head of Preclinical Development
Chief Medical Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Merck Médication Familiale S.A.S Europe
Laboratoires Bailleul-Biorga-S.A.R.L. Europe
Bional France SAS Europe
Keocyt SA Europe
Eudica SA Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Fovea Pharmaceuticals SA, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.